GEA-5024 | CAS# 144575-52-0 | Biochemical

MedKoo Cat#: 575842 | Name: GEA-5024

Description:

WARNING: This product is for research use only, not for human or veterinary use.

GEA-5024 is a nitric oxide-releasing compound.

Chemical Structure

GEA-5024

CAS#144575-52-0

Theoretical Analysis

MedKoo Cat#: 575842

Name: GEA-5024

CAS#: 144575-52-0

Chemical Formula: C8H10ClN4O

Exact Mass: 213.0543

Molecular Weight: 213.64

Elemental Analysis: C, 44.98; H, 4.72; Cl, 16.59; N, 26.22; O, 7.49

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

GEA-5024; GEA 5024; GEA5024

IUPAC/Chemical Name

1,2,3,4-Oxatriazolium, 5-amino-3-(3-chloro-2-methylphenyl)-, inner salt

InChi Key

BBEKNSDKHJONTM-UHFFFAOYSA-N

InChi Code

InChI=1S/C8H10ClN4O/c1-5-6(9)3-2-4-7(5)13-11-8(10)14-12-13/h2-4H,12H2,1H3,(H2,10,11)

SMILES Code

Cc1c(Cl)cccc1[N-]2[NH2+]OC(=N2)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 213.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1. Kapur S, Bédard S, Marcotte B, Côté CH, Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes. 1997 Nov;46(11):1691-700. doi: 10.2337/diab.46.11.1691. PMID: 9356014. 2. Wanikiat P, Woodward DF, Armstrong RA. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils. Br J Pharmacol. 1997 Nov;122(6):1135-45. doi: 10.1038/sj.bjp.0701477. PMID: 9401778; PMCID: PMC1565036.